Federated Hermes’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Federated Hermes’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-50,000	Closed	-$180K	–	2271
2018 Q4	$180K	Hold	50,000	–	–	﹤0.01%	1569
2018 Q3	$287K	Buy	+50,000	New	+$286K	﹤0.01%	1560
2017 Q1	–	Sell	-50,000	Closed	-$555K	–	2221
2016 Q4	$555K	Hold	50,000	–	–	﹤0.01%	1281
2016 Q3	$463K	Buy	+50,000	New	+$418K	﹤0.01%	1309
2016 Q1	–	Sell	-60,000	Closed	-$487K	–	2208
2015 Q4	$487K	Hold	60,000	–	–	﹤0.01%	1299
2015 Q3	$440K	Hold	60,000	–	–	﹤0.01%	1314
2015 Q2	$615K	Hold	60,000	–	–	﹤0.01%	1281
2015 Q1	$555K	Buy	60,000 +10,000	+20%	+$89.5K	﹤0.01%	1339
2014 Q4	$351K	Hold	50,000	–	–	﹤0.01%	1416
2014 Q3	$273K	Buy	+50,000	New	+$287K	﹤0.01%	1473

Other funds holding FOMX

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Federated Hermes's FOMX Position: Q1 2019 in Review

Federated Hermes sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2019, closing a stake of 50,000 shares — an estimated $180K sold.

Federated Hermes first reported a position in FOMX in Q3 2014 and held it in 10 quarters. The position peaked at $615K in Q2 2015. 62 funds tracked by Wall St. Rank hold FOMX as of Q1 2019.

Federated Hermes reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2019 after selling out during the quarter.
Federated Hermes sold 50,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2019, an estimated $180K.
Federated Hermes first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2014 and held it in 10 quarters.
Federated Hermes's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $615K in Q2 2015.
62 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2019.

Based on Federated Hermes's 13F filing for Q1 2019, filed 10 May 2019.